[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
Ohno
I
I
Ida
S
S
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents; D001419:Bacteria / Q000187:drug effects; D002939:Ciprofloxacin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D009643:Norfloxacin / Q000494:pharmacology* / Q000627:therapeutic use; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D010093:Oxolinic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010078:Oxazines; D011804:Quinolines; D002939:Ciprofloxacin; D015242:Ofloxacin; C037219:quinoline; D010093:Oxolinic Acid; D009643:Norfloxacin; C023981:miloxacin